EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Overview to Challenges in IBD 2024–2029

Caren Heller, Alan C Moss iD, David T Rubin

Inflammatory Bowel Diseases · 2024

DOI: 10.1093/ibd/izae092 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Inflammatory Bowel Diseases, 2024. Verfasst von Caren Heller und 2 weiteren Autor:innen. Beteiligte Einrichtung: Chief Scientific Officer (past and present), Crohn's & Colitis Foundation, New York, USA. Hauptthemen laut MEDLINE: Inflammatory Bowel Diseases. Die Arbeit wurde bisher 7-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The mission of the Crohn’s & Colitis Foundation is to cure Crohn’s disease and ulcerative colitis and to improve the quality of lives of patients living with these diseases—in other words, to care and cure. To achieve these missions, there is a need to identify and prioritize research gaps and approaches to address these gaps, which is the aim of Challenges in IBD 2024. The Foundation convened close to 80 experts in inflammatory bowel disease (IBD), including researchers, clinicians, patients and caregivers, funders, industry representatives, and Foundation scientific staff and organized them into 5 workgroups, one for each of the 5 Challenges topics: Preclinical Human IBD Mechanisms, Environmental Triggers, Precision Medicine, Novel Technologies, and Pragmatic Clinical Research. The findings of these groups outline a research agenda that intends to change the research paradigm in IBD by introducing 2 concepts in the course of IBD that warrant specific focus: interception (during the preclinical phase) and restoration of normal physiology after remission is achieved. We hope these reviews will stimulate innovations in our understanding and management of IBD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Inflammatory Bowel DiseasesHumansPrecision MedicineColitis, UlcerativeCrohn DiseaseBiomedical ResearchQuality of Life

Stichwörter der Autor:innen

Crohn’s diseaseinflammatory bowel diseaseulcerative colitis

Autor:innen und Institutionen

  • Chief Scientific Officer (past and present), Crohn's & Colitis Foundation, New York, USA.
  • Director of Inflammatory Bowel Disease Center, University of Chicago Medicine, Chicago, IL, USA.

ORCID-Profile: Alan C Moss

Zitieren

APA

Heller, C., Moss, A. C., & Rubin, D. T. (2024). Overview to Challenges in IBD 2024–2029. Inflammatory Bowel Diseases. https://doi.org/10.1093/ibd/izae092

Vancouver

Heller C, Moss AC, Rubin DT. Overview to Challenges in IBD 2024–2029. Inflammatory Bowel Diseases. 2024. doi:10.1093/ibd/izae092

BibTeX
@article{Heller2024,
  author = {Heller, Caren and Moss, Alan C and Rubin, David T},
  title = {Overview to Challenges in IBD 2024–2029},
  journal = {Inflammatory Bowel Diseases},
  year = {2024},
  doi = {10.1093/ibd/izae092}
}
Kostenlos starten →